Product Details
Jyna Darunavir Tablets 600 mg##
Emtricitabine; Tenofovir Disoproxil Fumarate200 mg; 300 mg
Tablet
ROA
Oral
Applicant Name
Jyna Pharma Ltd
NRN
A4-100044
Status
Active
Composition
Each film coated tablet contains: Emtricitabine 200 mg, Tenofovir disoproxil fumarate 300 mg equivalent to Tenofovir disoproxil 245 mg This medicinal product contains Lactose (Anhydrous) 145 mg in core and 8.40 mg (28.0 % of 30 mg) in the film coat of Lactose Monohydrate
ATC Code
J05AR03
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 30's, 1 x 90's (in HDPE bottles)
Product Description
Film coated tablet Blue colored, capsule shaped, film-coated biconvex tablets, debossed with “LA49” on one side and plain on the other side JYNA DARUNAVIR TABLETS 600 MG A4-100044 DARUNAVIR TABLETS 600 MG EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE ANTI-INFECTIVES ORAL 200 MG, 300 MG TABLET, FILM COATED PRESCRIPTION ONLY MEDICINE (POM) "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE INDICATED IN ANTIRETROVIRAL COMBINATION THERAPY FOR THE TREATMENT OF HIV-1 INFECTED ADULTS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE ALSO INDICATED FOR THE TREATMENT OF HIV-1 INFECTED ADOLESCENTS, WITH NRTI RESISTANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS ." JYNA PHARMA LTD NIGERIA LAURUS LABS INDIA 2021-05-07 2026-05-06
Manufacturer Name
Laurus Labs Limited
Manufacturer Country
INDIA
Approval Date
2021-05-07
Expiry Date
2026-05-06